Pfizer Gets New Trial After $39M Trade Secrets Verdict

Law360, New York (February 26, 2013, 11:31 PM ET) -- Pfizer Inc. will get a new trial after losing a $39 million dispute over trade secrets it allegedly stole from a California-based research group, when a California appeals court on Tuesday affirmed a lower court’s decision to grant the drug giant another shot.

The panel found that the research group The Ischemia Research and Education Foundation had brought up only its own evidence in its appeal of the lower court’s decision, and ruled that it did not do enough to counter Pfizer’s conflicting evidence that showed...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers